Business · 26/02/2015

FDA's Pediatric Stakeholder Meeting to Gather Input on Pediatric Drug Report

The FDA's Office of Pediatric Therapeutics, CDER, and CBER are hosting a public meeting to collect comments from patient groups, consumer groups, industry, academia, and other stakeholders on the report to Congress on pediatric drug issues, as mandated by the FDASIA.